Also the diabetogenic agent streptozotocin when injected at the intracerebro-ventricular level in rats can produce an Alzheimer disease (AD) model that triggers an insulin resistant brain state [65]. The gene discussed is INS; the disease is early-onset autosomal dominant Alzheimer disease.